Clinical trials
Injection clinical trials
Below are recruiting injection clinical trials, each written for real people, not researchers. We’re tracking 2,096 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07501559RecruitingPhase 1/Phase 2
Study of JL15003 for recurrent glioblastoma
This trial is testing a new drug (JL15003) given directly into the brain tumor using a small device called an Ommaya reservoir. It is for people whose glioblastoma has come back despite standard treatments. You will need to have had a polio vaccine booster before starting.
ShanghaiAges 18 years+ - NCT06787066RecruitingEarly Phase 1
Blood vessel study during menopause
This study looks at how blood vessels react to nerve signals during menopause. It may help explain why heart health changes after menopause.
Columbia, MissouriAges 18–70 - NCT06349213Recruiting
Understanding how our brain experiences time
This study uses brain scans and simple tasks to explore how young and older adults perceive time. It aims to uncover the mental and brain processes behind our sense of time.
CaenAges 20–85 - NCT07291232RecruitingPhase 1
Study of an injected drug for adults with obesity
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
Anaheim, CaliforniaAges 18–65 - NCT07661537RecruitingPhase 1
Study of SHR-3079 for B-cell Non-Hodgkin Lymphoma
This trial tests a new drug called SHR-3079 for people with B-cell non-Hodgkin lymphoma whose cancer did not get better or came back after at least one standard treatment. The goal is to see if the drug can help shrink tumors or slow the disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07733674RecruitingPhase 1
Testing a new imaging agent for brain and pancreatic tumors
This early-phase study tests a new imaging agent that may help see certain solid tumors (like brain cancer or pancreatic cancer) more clearly. You will receive a single injection of a radioactive tracer, then have several scans over a few days to see where the tracer goes and how long it stays.
Houston, TexasAges 18 years+ - NCT06402968Recruiting
Clevidipine for treating high blood pressure after a brain bleed
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
Irvine, CaliforniaAges 18–100 - NCT07036991Recruiting
Comparing two treatments for narrowed neck arteries
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
ShanghaiAges 18 years+ - NCT06438809RecruitingPhase 1/Phase 2
Stem cell injection for chronic radiation proctitis
This study tests whether a single injection of special cells (umbilical cord stem cells) can help heal long-term inflammation in the rectum caused by previous pelvic radiation. It's for people whose standard treatments have not worked.
Nanjing, JiangsuAges 18–79 - NCT05258396Recruiting
Remyelination study for teens with multiple sclerosis
This study tests whether the brain may “repair” itself (re-myelinate) in children and teens with multiple sclerosis. It uses brain MRI to look for changes and may help clinicians better understand how to treat MS in younger people.
Le Kremlin-BicêtreAges 12–18 - NCT03275584RecruitingPhase 4
Safety of an ammonia heart scan at CHUM
This trial checks how safe a specific heart scan is when used to look at blood flow to the heart. It is done as part of routine (clinically needed) testing at CHUM, using a special radioactive ammonia tracer.
Montreal, QuebecAges 18 years+ - NCT07744789Recruiting
Knee ligament stiffness and osteoarthritis treatment
This study looks at how knee ligament stiffness changes in people with knee osteoarthritis and compares it to healthy volunteers. It may help find better ways to treat knee pain and stiffness.
Taipei, Taipei CityAges 20 years+ - NCT07751042RecruitingPhase 1/Phase 2
Study of STX-003 with and without pembrolizumab for advanced solid tumors
This study tests an experimental drug called STX-1, given alone or with another drug that helps the immune system fight cancer. It is for people with advanced solid tumors, especially certain types of lung cancer or melanoma, who have already tried standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT06972680Enrolling by invitation
Finding the best dose for a shoulder block before surgery
This trial tests different volumes of a long-lasting numbing medicine (Exparel) injected around the shoulder nerves before arthroscopic surgery. The goal is to find the dose that provides the best pain relief.
Jiaxing, ZhejiangAges 18 years+ - NCT06985368RecruitingPhase 1
Testing SIBP-A18 for advanced solid tumors
This trial tests a new drug, SIBP-A18, for people with advanced solid tumors that have not responded to standard treatments. It may be an option for those with certain cancers that have a protein called CLDN18.2.
Beijing, Beijing MunicipalityAges 18–75 - NCT06992687Enrolling by invitationPhase 1/Phase 2
Study of HB0052 for advanced solid tumors
This trial tests a new drug called HB0052 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for various cancer types.
BeijingAges 18 years+ - NCT06952075RecruitingPhase 2
GR1803 for Multiple Myeloma with Soft Tissue Spread
This trial tests an experimental drug called GR1803 for people with multiple myeloma that has spread to soft tissue areas outside the bone. The goal is to see if it can help shrink these tumors.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06844474RecruitingPhase 2
Study of SHR-1826 for advanced lung cancer
This trial tests an investigational drug called SHR-1826 for people with non-small cell lung cancer that has spread or cannot be removed by surgery. It aims to see if the drug can shrink tumors and improve outcomes.
Beijing, Beijing MunicipalityAges 18–75 - NCT06840821RecruitingPhase 1/Phase 2
Testing MB0151 for cancers with somatostatin receptors
This trial tests a new drug, MB0151, for adults with advanced solid tumors that have somatostatin receptors and have not responded to standard treatments. It aims to see if MB0151 is safe and can shrink tumors.
Jinan, ShandongAges 18 years+ - NCT06811649Recruiting
Ultrasound vs. traditional epidural placement for labor pain
This study compares two ways of placing an epidural catheter for pain relief during labor. One method uses ultrasound (a type of imaging) to guide the needle, while the other uses the traditional touch-based approach. The goal is to see which is more effective and easier for the patient.
BolognaAges 18–50 - NCT06794294RecruitingPhase 1/Phase 2
Stem cell therapy for chronic shoulder pain from partial rotator cuff tear
This trial tests whether a single injection of stem cells from donated umbilical cord tissue can help people with a partial rotator cuff tear that hasn't healed with standard treatments like physical therapy or injections. If you have had shoulder pain for at least 3 months and a partial tear confirmed by MRI or ultrasound, you may be eligible.
Seoul, KoreaAges 19 years+ - NCT06769191RecruitingEarly Phase 1
CD7 car-t, stem cell transplant, and kidney transplant for SIOD
This trial tests a sequence of treatments for SIOD (a genetic condition causing immune and kidney problems). First, you receive CD7 car-t cells, then a stem cell transplant from a family donor, followed by a kidney transplant from the same donor. The goal is to see if this approach is safe and can help your body accept the new kidney.
Hangzhou, ZhejiangAges Any age - NCT06779136RecruitingPhase 3
Study of MG-K10 for prurigo nodularis
This trial tests an investigational drug called MG-K10 for people with prurigo nodularis, a skin condition that causes intense itching and bumps. The goal is to see if it can help reduce itch and improve skin.
Beijing, BejingAges 18–80 - NCT06666309Enrolling by invitation
Study on HIV prevention for people who inject drugs
This study tests different ways to help people who inject drugs stay on PrEP, a daily pill that prevents HIV. It's for people who are HIV-negative and have recently injected drugs.
Barbourville, KentuckyAges 18 years+
Hear when a new Injection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for injection?
- Yes. Clin2 currently lists 2,096 recruiting injection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a injection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a injection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.